Invesco Biotechnology & Genome ETF (PBE)
- Previous Close
59.85 - Open
59.89 - Bid 60.34 x 1100
- Ask 61.50 x 1000
- Day's Range
60.32 - 60.62 - 52 Week Range
52.47 - 67.76 - Volume
6,904 - Avg. Volume
15,193 - Net Assets 245.86M
- NAV 59.88
- PE Ratio (TTM) 16.01
- Yield 0.06%
- YTD Daily Total Return -9.06%
- Beta (5Y Monthly) 0.81
- Expense Ratio (net) 0.58%
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Invesco
Fund Family
Health
Fund Category
245.86M
Net Assets
2005-06-23
Inception Date
Performance Overview: PBE
Trailing returns as of 4/25/2024. Category is Health.
People Also Watch
Holdings: PBE
Top 10 Holdings (46.40% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: PBE
Analyst Report: United Airlines Holdings Inc
Based in Chicago, United Airlines Holdings is a global airline that transports passengers and freight through both mainline and regional operations. With a market cap of about $13.6 billion, United Airlines is generally regarded as a large-cap value stock.
RatingPrice TargetAnalyst Report: American Water Works Company, Inc.
American Water Works is the largest investor-owned US water and wastewater utility, serving approximately 3.5 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns.
RatingPrice TargetAnalyst Report: Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
RatingPrice TargetAnalyst Report: Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest cruise company by berths (around 66,500). It operates 32 ships across three brands —Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With five passenger vessels on order among its brands through 2028, representing 16,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
RatingPrice Target